A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.

O'Connor, Owen A; Portlock, Carol; Moskowitz, Craig; Straus, David; Hamlin, Paul; Stubblefield, Michael; Dumetrescu, Otila; Colevas, A Dimitrios; Grant, Barbara; Zelenetz, Andrew

O'Connor, Owen A; Portlock, Carol; Moskowitz, Craig; Straus, David; Hamlin, Paul; Stubblefield, Michael; Dumetrescu, Otila; Colevas, A Dimitrios; Grant, Barbara; Zelenetz, Andrew.

Affiliation

O'Connor OA; Department of Medicine, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, Lymphoma Service, New York, NY 10032, USA. oo2130@columbia.edu

Br J Haematol ; 143(2): 201-9, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18691173

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Mantle-Cell / Epothilones / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google